Clopidogrel and coronary stenting: what is the next question?
- 1 January 2000
- journal article
- research article
- Published by Springer Nature in Journal of Thrombosis and Thrombolysis
- Vol. 10 (2) , 121-126
- https://doi.org/10.1023/a:1018706324908
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- A Randomized Comparison of Clopidogrel and Aspirin Versus Ticlopidine and Aspirin After the Placement of Coronary-Artery StentsCirculation, 2000
- Meeting HighlightsCirculation, 1999
- Intracoronary Stenting and Risk for Major Adverse Cardiac Events During the First MonthCirculation, 1998
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- A Randomized Comparison of Antiplatelet and Anticoagulant Therapy after the Placement of Coronary-Artery StentsNew England Journal of Medicine, 1996
- Increasing mortality from thrombotic thrombocytopenic purpura in the United States—analysis of national mortality data, 1968–1991American Journal of Hematology, 1995
- Antiplatelet DrugsDrugs, 1995
- Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk PatientsNew England Journal of Medicine, 1989
- THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKEThe Lancet, 1989